Nunez E A, Horwith M, Krook L, Whalen J P
Am J Pathol. 1979 Jan;94(1):1-18.
Familial bone dysplasia with hyperphosphatasemia is characterized by excessive bone resorption early in life with resulting severe skeletal deformity. The disease can be ameliorated by treatment with human calcitonin. We have the studied the ultrastructure of bone from diseased patients before treatment and at intervals during 1 year of treatment with calcitonin. Pretreatment osteoblasts, osteoclasts, and osteocytes exhibited mitochondria which contained vast amounts of dense microcrystal deposits. Osteocytes were also distinguished by minimal organellar development. Osteoclasts were rare. Calcitonin treatment included a progressive development of a more normal bone structure. Intramitochondrial crystal deposits were absent in mitochondria of osteocytes and osteoclasts but were still present in mitochondria of osteoblasts. Surprisingly, the developing bony matrix during calcitonin treatment exhibited large numbers of elastic fibers. These appeared to develop normally in alignment with the surface membrane of osteocytes. Calcitonin treatment caused a proliferation of osteocyte organellar development. It is concluded that familial bone dysplasia is primarily a disease of osteocytes and that osteocytic activity is influenced by calcitonin.
伴有高磷酸酶血症的家族性骨发育异常的特征是在生命早期骨吸收过度,导致严重的骨骼畸形。该疾病可用人降钙素治疗改善。我们研究了患病患者治疗前以及降钙素治疗1年期间不同时间点的骨超微结构。治疗前的成骨细胞、破骨细胞和骨细胞的线粒体含有大量致密的微晶沉积物。骨细胞的特点还包括细胞器发育极少。破骨细胞罕见。降钙素治疗使骨结构逐渐发展为更正常的状态。骨细胞和破骨细胞的线粒体中没有线粒体内晶体沉积物,但成骨细胞的线粒体中仍有。令人惊讶的是,降钙素治疗期间正在形成的骨基质中有大量弹性纤维。这些弹性纤维似乎与骨细胞的表面膜正常排列生长。降钙素治疗导致骨细胞细胞器发育增殖。结论是家族性骨发育异常主要是一种骨细胞疾病,且骨细胞活性受降钙素影响。